BLUESTEIN R H & CO LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 13 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BLUESTEIN R H & CO LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$36,000
-53.8%
76,500
-31.8%
0.00%
-60.0%
Q3 2016$78,000
-77.7%
112,200
-36.2%
0.01%
-81.5%
Q2 2016$350,000
-21.9%
175,905
-5.4%
0.03%
-15.6%
Q1 2016$448,000
-72.7%
185,975
-13.1%
0.03%
-68.9%
Q4 2015$1,642,000
+14.9%
214,125
-20.7%
0.10%
+1.0%
Q3 2015$1,429,000
-55.9%
270,075
-25.3%
0.10%
-48.2%
Q2 2015$3,243,000
+63.3%
361,575
+15.1%
0.20%
+64.2%
Q1 2015$1,986,000
-4.8%
314,170
-12.1%
0.12%
-7.7%
Q4 2014$2,086,000
-22.0%
357,250
-8.5%
0.13%
-22.6%
Q3 2014$2,675,000
-27.0%
390,550
+53.0%
0.17%
-22.9%
Q2 2014$3,663,000
+23.0%
255,250
-10.8%
0.22%
+10.7%
Q1 2014$2,978,000
+60.6%
286,100
+59.1%
0.20%
+68.4%
Q4 2013$1,854,000
+1937.4%
179,800
+619.2%
0.12%
+1850.0%
Q3 2013$91,00025,0000.01%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2013
NameSharesValueWeighting ↓
Opaleye Management Inc. 800,000$1,592,0001.06%
PURA VIDA INVESTMENTS, LLC 284,877$567,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,097,248$4,174,0000.23%
Broadfin Capital, LLC 433,911$863,0000.08%
SABBY MANAGEMENT, LLC 585,914$1,166,0000.06%
FNY Managed Accounts LLC 26,000$51,740,0000.05%
BLUESTEIN R H & CO LLC 175,905$350,0000.03%
FT Options LLC 15,000$30,0000.03%
Klingman & Associates, LLC 10,000$20,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 103,900$207,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders